Elevating CMV Monitoring with the power of RNAemia

Human cytomegalovirus (HCMV) infects most adults worldwide and typically remains asymptomatic in healthy individuals. In immunocompromised patients, particularly solid organ (SOT) and hematopoietic stem cell (HSCT) transplant recipients, HCMV infection is associated with significant morbidity, graft dysfunction, and increased mortality, underscoring the need for accurate virus monitoring.